Skip to main content
Clinical Trials/NCT02971020
NCT02971020
Completed
N/A

Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.

Minnesota Veterans Medical Research and Education Foundation1 site in 1 country63 target enrollmentMay 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
Minnesota Veterans Medical Research and Education Foundation
Enrollment
63
Locations
1
Primary Endpoint
Montreal Cognitive Assessment
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The investigators are conducting a pilot study to compare cognitive outcomes among Veterans with severe aortic valve stenosis who are scheduled to undergo either aortic valve replacement.

Detailed Description

The investigators are conducting a pilot study to compare cognitive outcomes in up to 60 Veterans with severe aortic valve stenosis who are scheduled to undergo either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) at the Minneapolis VA Health Care System. Participants will be administered a short battery of cognitive tests before and three months after TAVR or SAVR over/up to a two year study period.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
March 21, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Minnesota Veterans Medical Research and Education Foundation
Responsible Party
Principal Investigator
Principal Investigator

Santiago Garcia

MD

Minnesota Veterans Medical Research and Education Foundation

Eligibility Criteria

Inclusion Criteria

  • Severe aortic stenosis (AVA: 1 cm2 and/or mean gradient =or \> 40 mmHg and/or peak velocity \> 4 m/s)
  • Scheduled to undergo either surgical or transcatheter aortic valve replacement at the Minneapolis VA Health Care System

Exclusion Criteria

  • Severe cognitive impairment at baseline (i.e. unable to understand or follow-up study procedures)
  • Unable or unwilling to provide informed consent

Outcomes

Primary Outcomes

Montreal Cognitive Assessment

Time Frame: Three Months

Estimate the means and standard deviations of changes in selected cognitive measures between baseline (pre-TAVR or pre-SAVR) and 3 months post-TAVR or post-SAVR, identify baseline correlates of those changes, and characterize baseline cognitive function and cognitive history of patients who undergo TAVR or SAVR.

Trail Making

Time Frame: 3 months

Study Sites (1)

Loading locations...

Similar Trials